Linda Llewelyn - Feb 1, 2022 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
Chief People Officer
Signature
/s/ Daniel Orenstein, as Attorney-in-Fact
Stock symbol
HCAT
Transactions as of
Feb 1, 2022
Transactions value $
-$21,120
Form type
4
Date filed
2/3/2022, 04:30 PM
Previous filing
Jan 6, 2022
Next filing
Feb 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Options Exercise $11.9K +1.1K +3.56% $10.80 32K Feb 1, 2022 Direct
transaction HCAT Common Stock Sale -$33K -1.1K -3.44% $30.00 30.9K Feb 1, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCAT Stock Option (Right to Buy) Options Exercise $0 -1.1K -15.9% $0.00 5.82K Feb 1, 2022 Common Stock 1.1K $10.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December 9, 2020, in accordance with Rule 10b5-1.
F2 25% of the 59,351 shares underlying the options vested in an annual installment on September 25, 2019 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on September 25, 2022.